The Atosiban Market Volume is poised for unprecedented growth, with significant implications for maternal healthcare. Recent projections indicate that the market is expected to increase from USD 0.79 million in 2024 to an estimated USD 1.528 million by 2035, reflecting a substantial compound annual growth rate (CAGR) of 6.18%. This surge is not merely a numbers game; it represents a vital shift...